Back to Journals » OncoTargets and Therapy » Volume 17 » A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report
Please verify you are not a robot.